Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Supplementary Financial Statement Information

v3.22.1
Supplementary Financial Statement Information
12 Months Ended
Dec. 31, 2021
Supplementary Financial Statement Information [Abstract]  
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:

 

Balance sheets:

 

    December 31  
    2021     2020    
a. Accrued liabilities and other:      
Employees and institutions for employees   $ 863     $ 671  
Provisions for vacation and others     473       360  
Royalties and Other     93       912  
    $ 1,429     $ 1,943  

 

Statements of operations:

 

b. Revenues

 

  1) Disaggregated revenues

 

    Year ended December 31  
    2021   2020   2019  
Revenues from licensing agreement (see Note 2(p))   $ 14,000   $ 3,600   $
-
 
Revenues from the sales of goods     1,595     2,108     1,949  
Revenues from the rendering of services     46     429     369  
Total revenues   $ 15,641   $ 6,137   $ 2,318  

 

  2) Revenues by geographical area (based on the location of customers):

 

    Year ended December 31  
    2021   2020   2019  
United states and Canada   $ 15,013   $ 5,768   $ 2,078  
Europe     628     369     240  
Total revenues   $ 15,641   $ 6,137   $ 2,318  

 

  3) Major customers

 

Set forth below is a breakdown of the Company’s revenue by major customers (major customer –revenues from these customers constitute at least 10% of total revenues in a certain year):

 

    2021   2020   2019  
Customer  A   $ 169   $ 4,929   $ 1,374  
                     
Customer B   $ 14,770   $ 822   $ 242  
                     
Customer C   $
-
  $
-
  $ 419  

 

  4) The changes in deferred revenues relating to goods that were not yet delivered are as follows:

 

    2021   2020   2019  
Balance at beginning of year   $ (207 ) $ (942 ) $ (1,950 )
Contract liability recognized during the period     (32 )   (270 )  
-
 
Revenue recognized during the period     207     1,005     1,008  
                     
Balance at end of year(1)     (32 )   (207 )   (942 )
Contract liability presented in current liabilities     (32 )   (207 )   (942 )
Contract liability presented in non-current liabilities    
-
   
-
   
-
 

 

(1) Balance for the year ended December 31, 2019 represents the unfulfilled performance obligation related to First BioInk.

 

c. Long-lived assets

 

All of the Company’s long-lived assets are located in Israel.

 

d. Financial income (expenses) ,net

 

    Year ended December 31  
    2021     2020     2019  
                   
Exchange rate differences   $ (38 )   $ (181 )   $ (230 )
Bank and other fees     (30 )     (11 )     (63 )
Remeasurement of financial instruments     28       40       (3,230 )
Other financing expenses     (7 )     (23 )     (10 )
Interest on bank deposits     219      
-
     
-
 
Financial income (expenses), net   $ 172     $ (175 )   $ (3,533 )